Kyverna Therapeutics Inc’s filing revealed that its Director SEIDENBERG BETH C acquired Company’s shares for reported $1.0 million on Dec 18 ’25. In the deal valued at $7.50 per share,133,333 shares were bought. As a result of this transaction, SEIDENBERG BETH C now holds 869,317 shares worth roughly $7.07 million.
Then, Westlake BioPartners Opportuni bought 133,333 shares, generating $999,998 in total proceeds. Upon buying the shares at $7.50, the 10% Owner now owns 869,317 shares.
Before that, Walker Karen Marie sold 23,998 shares. Kyverna Therapeutics Inc shares valued at $292,776 were divested by the Chief Technology Officer at a price of $12.20 per share. As a result of the transaction, Walker Karen Marie now holds 22,636 shares, worth roughly $0.18 million.
William Blair initiated its Kyverna Therapeutics Inc [KYTX] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who increased its forecast for the stock in late May from “a Neutral” to “a Buy”. UBS began covering KYTX with “Buy” recommendation on October 10, 2024. Rodman & Renshaw started covering the stock on October 09, 2024. It rated KYTX as “a Buy”.
Price Performance Review of KYTX
On Monday, Kyverna Therapeutics Inc [NASDAQ:KYTX] saw its stock jump 13.07% to $8.13. Over the last five days, the stock has lost -24.86%. Kyverna Therapeutics Inc shares have risen nearly 114.51% since the year began. Nevertheless, the stocks have risen 117.38% over the past one year. While a 52-week high of $13.67 was reached on 12/15/25, a 52-week low of $1.78 was recorded on 04/17/25.
Levels Of Support And Resistance For KYTX Stock
The 24-hour chart illustrates a support level at 7.41, which if violated will result in even more drops to 6.70. On the upside, there is a resistance level at 8.62. A further resistance level may holdings at 9.10.
How much short interest is there in Kyverna Therapeutics Inc?
A steep rise in short interest was recorded in Kyverna Therapeutics Inc stocks on 2025-11-28, growing by 0.83 million shares to a total of 3.53 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 2.7 million shares. There was a rise of 23.61%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 03, 2024 when H.C. Wainwright began covering the stock and recommended ‘”a Neutral”‘ rating along with a $8 price target.
